BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia
scientific article published on 14 August 2014
Author/s
author: Richard A. Larson, Brian Druker, Richard D Press, Delphine Rea, Simona Soverini, Hagop Kantarjian, Anna M Eiring, Gianantonio Rosti, Michele Baccarani, Marina Konopleva, Jorge Eduardo Cortes, Elias Jabbour, Steven M Kornblau, Meir Wetzler, Charles Chuah, Hanna J Khoury, Franck E Nicolini, Leif Stenke, Gert J Ossenkoppele, Francois-Xavier Mahon, Philippe Rousselot, Thoralf Lange, Christopher A Eide
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.